Most Read Articles
Elvira Manzano, 3 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 3 days ago
For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.

Use of other nicotine products common among vapers

05 Oct 2018
Vaping can help cut rates of smoking, says Reason Foundation think tank

Majority of users of electronic nicotine delivery systems (ENDS) also use other tobacco products, a recent study has shown.

Researchers surveyed a nationally representative sample of 3,517 adolescents and young adults, of whom only 281 (20.4 percent aged 13–17 years; 61.2 percent male) reported past 30-day ENDS use. Logistic regression analysis was employed to determine the probability of being an exclusive ENDS user.

More than half of the participants reported polytobacco use, (n=156; 17.2 percent aged 13–17 years), most of whom were male (65.5 percent). Only 44.1 percent (n=125; 24.3 percent aged 13–17 years; 55.9 percent male) used ENDS exclusively.

The most common tobacco product used with ENDS were cigarettes (11.5 percent) followed by cigars (7.7 percent), both cigars and water pipes (5.2 percent), water pipes alone (4.5 percent), and both cigarettes and cigars (4.0 percent).

Majority of the reported polytobacco involved only one (50.3 percent) or two (32.3 percent) other products; more than a tenth (13.4 percent) used three products with ENDS.

Multivariable adjusted analysis showed that risk perception was an important factor, such that those who viewed ENDS as less harmful than cigarettes were significantly more likely to be exclusive users than those who perceived ENDS to be as or more harmful than cigarettes (adjusted odds ratio, 2.6; 95 percent CI, 1.2–5.7).

No other factor, such as frequency of ENDS use, age, sex and socioeconomic status, was significantly predictive of polytobacco or exclusive patterns of use.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 3 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 3 days ago
For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.